# Safety, Tolerability and Pharmacokinetics of ETD-001 Gel

> **NCT07674862** · PHASE1 · COMPLETED · sponsor: **Etern Therapeutics Wuxi Limited** · enrollment: 56 (actual)

## Conditions studied

- Safety Issues

## Interventions

- **DRUG:** Dose 1
- **DRUG:** dose 2
- **DRUG:** dose 3

## Key facts

- **NCT ID:** NCT07674862
- **Lead sponsor:** Etern Therapeutics Wuxi Limited
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-03-16
- **Primary completion:** 2026-07-05
- **Final completion:** 2026-08-30
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07674862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07674862, "Safety, Tolerability and Pharmacokinetics of ETD-001 Gel". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07674862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*